Jubilant Pharmova share news, announcements and annual reports
NSE: JUBLPHARMABSE: 530019Pharmaceuticals & BiotechnologySmall Cap
Jubilant Pharmova Limited · Formerly Jubilant Life Sciences · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jun 1981 on BSE, Jun 2003 on NSE
Last close ₹923.80down ₹22.20 (2.35%)BSE ₹924.70
Share price at the NSE close on 30 Oct 2026. Previous close ₹946.00.
30 Oct: open ₹946.00, high ₹951.80, low ₹920.00
52-week range of traded prices to 30 Oct 2026
₹786.05Low, 9 Mar 2026₹1,183.00High, 4 Nov 2025
- Next results date: the board meets on 13 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹14,714 Cr422nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 41.79
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 35.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.07
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.54%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 5.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹59 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 6.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.45
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 56,22937.1% delivered
Jubilant Pharmova shareholding disclosures
93 filed, newest first. Page 2 of 2.
Mar 2013
Feb 2013
Dec 2012
6 Dec · Disclosure
Compensation Committee of the Board of Directors have on December 05, 2012, granted 8,84,190 (Eight Lacs Eighty Four Thousand One Hundred Ninety) Options to eligible employees and Independent Directors of the Company, in accordance with JLL Employees Stock Option Plan, 2011. Each option shall entitle the holder to acquire 1 equity share of Re. 1 of the Company at a price of Rs. 220.90 per share. Since Jubilant Employees Welfare Trust is holding sufficient number of equity shares of the Company, it is envisaged to transfer the Shares from the Trust to beneficiaries upon exercise. As such, there would be no fresh issue of Shares by the Company and hence no dilution.
Jul 2012
23 Jul · Disclosure
At a Meeting of the Compensation Committee of the Board of Directors held on July 23, 2012, 34,161 (Thirty Four Thousand One Hundred Sixty One) Options have been granted to eligible employees, in accordance with JLL Employees Stock Option Plan, 2011. Each option shall entitle the holder to acquire 1 equity share of Re. 1 of the Company at a price of Rs 170.20 per share. Since Jubilant Employees Welfare Trust is holding sufficient number of equity shares of the Company, it is envisaged to transfer the Shares from the Trust to beneficiaries upon exercise. As such, there would be no fresh issue of Shares by the Company and hence no dilution.
Feb 2012
6 Feb · Disclosure
At a Meeting of the Compensation Committee of the Board of Directors held on February 06, 2012, 28,922 (Twenty Eight Thousand Nine Hundred and Twenty Two) Options have been granted to eligible employees, in accordance with JLL Employees Stock Option Plan, 2011. Each option shall entitle the holder to acquire 1 equity share of Re. 1 of the Company at a price of Rs 174.90 per share. Since Jubilant Employees Welfare Trust is holding sufficient number of equity shares of the Company, it is envisaged to transfer the Shares from the Trust to beneficiaries upon exercise. As such, there would be no fresh issue of Shares by the Company and hence no dilution.
Dec 2011
Oct 2011
25 Oct · Disclosure
At a meeting of the Compensation Committee of the Board of Directors held on October 24, 2011, 8,62,461 (Eight Lacs Sixty Two Thousand Four Hundred Sixty One) Options have been granted to eligible employees / directors of the Company and its subsidiaries, in accordance with JLL Employees Stock Option Plan, 2011. Each option shall entitle the holder to acquire 1 equity share of Re. 1 of the Company at a price of Rs. 200.05 per share.Since Jubilant Employees Welfare Trust is holding sufficient number of equity shares of the Company, it is envisaged to transfer the Shares from the Trust to beneficiaries upon exercise. As such, there would be no fresh issue of Shares by the Company and hence no dilution.
Sep 2011
Aug 2011
Jul 2011
May 2011
Feb 2011
Jan 2011
Dec 2010
Oct 2010
Sep 2010
14 Sep · Disclosure
By a Resolution by Circulation dated September 13, 2010 the Compensation Committee of the Board of Directors has approved transfer by Jubliant Employees Welfare Trust to the option holders 3,19,605 equity shares of Re.1 each on exercise of 63,921 options, as per details below : Rs.201.33 per share for 3,17,205 equity shares; Rs.258.25 per share for 1,800 equity shares and; Rs.309.00 per share for 600 Shares.
Aug 2010
Jul 2010
27 Jul · Disclosure
At a meeting of the Compensation Committee of the Board of Directors held on July 27, 2010, pursuant to exercise of 32,842 options, the Committee has approved transfer by Jubilant Employees Welfare Trust to the option holders, of equity shares of Re. 1 each at an exercise price of Rs. 201.33 per share for 145,010 equity shares and Rs. 258.25 per share for 19,200 equity shares.
May 2010
10 May · Disclosure
At a Meeting of the Compensation Committee of the Board of Directors held on May 10, 2010, pursuant to exercise of 51,532 options, the Committee has approved transfer by Jubilant Employees Welfare Trust to the option holders, of equity shares of Re. 1 each at an exercise price of: (1) Rs. 201.33 per share for 2,56,860 equity shares and (2) Rs. 198.55 per share for 800 equity shares.
Nov 2009
5 Nov · Disclosure
Disclosures of pledge of shares under Regulation 8A(4) of SEBI (SAST) Regulations, 1997. The promoters and promoter group hold 50.82% of the Company's capital, out of which 9.65% is pledged. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Oct 2009
28 Oct · Disclosure
Disclosures of pledge of shares under Regulation 8A(4) of SEBI (SAST) Regulations, 1997. The promoters and promoter group hold 50.82% of the Company's capital, out of which 10.64% is pledged. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.26 Oct · Disclosure
Disclosures dated October 19, 2009, the promoters and promoter group hold 50.82% of the Company's capital, out of which 10.89% is pledged. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Feb 2009
6 Feb · Disclosure
As per Regulation 8A(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 1997, the promoters and promoter group hold 50.41% of the Company's capital, out of which 13.66% is pledged. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.